Hernández-Jiménez, T.; Ferro-Flores, G.; Morales-Ávila, E.; Isaac-Olivé, K.; Ocampo-García, B.; Aranda-Lara, L.; Santos-Cuevas, C.; Luna-Gutiérrez, M.; De Nardo, L.; Rosato, A.;
et al. 225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins. Molecules 2022, 27, 2156.
https://doi.org/10.3390/molecules27072156
AMA Style
Hernández-Jiménez T, Ferro-Flores G, Morales-Ávila E, Isaac-Olivé K, Ocampo-García B, Aranda-Lara L, Santos-Cuevas C, Luna-Gutiérrez M, De Nardo L, Rosato A,
et al. 225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins. Molecules. 2022; 27(7):2156.
https://doi.org/10.3390/molecules27072156
Chicago/Turabian Style
Hernández-Jiménez, Tania, Guillermina Ferro-Flores, Enrique Morales-Ávila, Keila Isaac-Olivé, Blanca Ocampo-García, Liliana Aranda-Lara, Clara Santos-Cuevas, Myrna Luna-Gutiérrez, Laura De Nardo, Antonio Rosato,
and et al. 2022. "225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins" Molecules 27, no. 7: 2156.
https://doi.org/10.3390/molecules27072156
APA Style
Hernández-Jiménez, T., Ferro-Flores, G., Morales-Ávila, E., Isaac-Olivé, K., Ocampo-García, B., Aranda-Lara, L., Santos-Cuevas, C., Luna-Gutiérrez, M., De Nardo, L., Rosato, A., & Meléndez-Alafort, L.
(2022). 225Ac-rHDL Nanoparticles: A Potential Agent for Targeted Alpha-Particle Therapy of Tumors Overexpressing SR-BI Proteins. Molecules, 27(7), 2156.
https://doi.org/10.3390/molecules27072156